https://www.usatoday.com/story/news/health/2023/05/03/fda-approves-first-rsv-vaccine-older-adults/70178303007/
Trial data showed the new vaccine, developed by GlaxoSmithKline, was 82% effective at preventing lower respiratory tract illness caused by RSV.
Create an account
or login to join the discussion